Testing of Oxford vaccine will continue after volunteer dies

Brazil health authority Anvisa said on Wednesday that trials of the COVID-19 vaccine developed by AstraZeneca and University of Oxford would continue after the death of volunteer involved in the tests.
Anvisa gave no further details on the death, citing confidentiality protocols.
Subscribe for our daily newsletter
Subscribe for our daily newsletter

By subscribing I accept the terms of use and privacy policy